Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening

Authors: Valérie D. V. Sankatsing, Jacques Fracheboud, Linda de Munck, Mireille J. M. Broeders, Nicolien T. van Ravesteyn, Eveline A. M. Heijnsdijk, André L. M. Verbeek, Johannes D. M. Otten, Ruud M. Pijnappel, Sabine Siesling, Harry J. de Koning, National Evaluation Team for Breast cancer screening, NETB

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Between 2003 and 2010 digital mammography (DM) gradually replaced screen-film mammography (SFM) in the Dutch breast cancer screening programme (BCSP). Previous studies showed increases in detection rate (DR) after the transition to DM. However, national interval cancer rates (ICR) have not yet been reported.

Methods

We assessed programme sensitivity and specificity during the transition period to DM, analysing nationwide data on screen-detected and interval cancers. Data of 7.3 million screens in women aged 49–74, between 2004 and 2011, were linked to the Netherlands Cancer Registry to obtain data on interval cancers. Age-adjusted DRs, ICRs and recall rates (RR) per 1000 screens and programme sensitivity and specificity were calculated by year, age and screening modality.

Results

41,662 screen-detected and 16,160 interval cancers were analysed. The DR significantly increased from 5.13 (95% confidence interval (CI):5.00–5.30) in 2004 to 6.34 (95% CI:6.15–6.47) in 2011, for both in situ (2004:0.73;2011:1.24) and invasive cancers (2004:4.42;2011:5.07), whereas the ICR remained stable (2004: 2.16 (95% CI2.06–2.25);2011: 2.13 (95% CI:2.04–2.22)). The RR changed significantly from 14.0 to 21.4. Programme sensitivity significantly increased, mainly between ages 49–59, from 70.0% (95% CI:68.9–71.2) to 74.4% (95% CI:73.5–75.4) whereas specificity slightly declined (2004:99.1% (95% CI:99.09–99.13);2011:98.5% (95% CI:98.45–98.50)). The overall DR was significantly higher for DM than for SFM (6.24;5.36) as was programme sensitivity (73.6%;70.1%), the ICR was similar (2.19;2.20) and specificity was significantly lower for DM (98.5%;98.9%).

Conclusions

During the transition from SFM to DM, there was a significant rise in DR and a stable ICR, leading to increased programme sensitivity. Although the recall rate increased, programme specificity remained high compared to other countries. These findings indicate that the performance of DM in a nationwide screening programme is not inferior to, and may be even better, than that of SFM.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Verbeek AL, Hendriks JH, van Ineveld BM, Broeders MJ, de Bruyn AE, van der Maas PJ. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer. 1999;81(5):912–7.CrossRefPubMedPubMedCentral Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Verbeek AL, Hendriks JH, van Ineveld BM, Broeders MJ, de Bruyn AE, van der Maas PJ. Interval cancers in the Dutch breast cancer screening programme. Br J Cancer. 1999;81(5):912–7.CrossRefPubMedPubMedCentral
2.
go back to reference Hofvind S, Yankaskas BC, Bulliard JL, Klabunde CN, Fracheboud J. Comparing interval breast cancer rates in Norway and North Carolina: results and challenges. J Med Screen. 2009;16(3):131–9.CrossRefPubMed Hofvind S, Yankaskas BC, Bulliard JL, Klabunde CN, Fracheboud J. Comparing interval breast cancer rates in Norway and North Carolina: results and challenges. J Med Screen. 2009;16(3):131–9.CrossRefPubMed
3.
go back to reference Bennett RL, Sellars SJ, Moss SM. Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland. Br J Cancer. 2011;104(4):571–7.CrossRefPubMedPubMedCentral Bennett RL, Sellars SJ, Moss SM. Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland. Br J Cancer. 2011;104(4):571–7.CrossRefPubMedPubMedCentral
4.
go back to reference Dibden A, Offman J, Parmar D, Jenkins J, Slater J, Binysh K, McSorley J, Scorfield S, Cumming P, Liao XH, et al. Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme. Br J Cancer. 2014;110(3):560–4.CrossRefPubMed Dibden A, Offman J, Parmar D, Jenkins J, Slater J, Binysh K, McSorley J, Scorfield S, Cumming P, Liao XH, et al. Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme. Br J Cancer. 2014;110(3):560–4.CrossRefPubMed
5.
go back to reference Del Turco MR, Mantellini P, Ciatto S, Bonardi R, Martinelli F, Lazzari B, Houssami N. Full-field digital versus screen-film mammography: comparative accuracy in concurrent screening cohorts. AJR Am J Roentgenol. 2007;189(4):860–6.CrossRefPubMed Del Turco MR, Mantellini P, Ciatto S, Bonardi R, Martinelli F, Lazzari B, Houssami N. Full-field digital versus screen-film mammography: comparative accuracy in concurrent screening cohorts. AJR Am J Roentgenol. 2007;189(4):860–6.CrossRefPubMed
6.
go back to reference Hambly NM, McNicholas MM, Phelan N, Hargaden GC, O'Doherty A, Flanagan FL. Comparison of digital mammography and screen-film mammography in breast cancer screening: a review in the Irish breast screening program. AJR Am J Roentgenol. 2009;193(4):1010–8.CrossRefPubMed Hambly NM, McNicholas MM, Phelan N, Hargaden GC, O'Doherty A, Flanagan FL. Comparison of digital mammography and screen-film mammography in breast cancer screening: a review in the Irish breast screening program. AJR Am J Roentgenol. 2009;193(4):1010–8.CrossRefPubMed
7.
go back to reference Vinnicombe S, Pinto Pereira SM, McCormack VA, Shiel S, Perry N, Dos Santos Silva IM. Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data. Radiology. 2009;251(2):347–58.CrossRefPubMed Vinnicombe S, Pinto Pereira SM, McCormack VA, Shiel S, Perry N, Dos Santos Silva IM. Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data. Radiology. 2009;251(2):347–58.CrossRefPubMed
8.
go back to reference Timmers JM, den Heeten GJ, Adang EM, Otten JD, Verbeek AL, Broeders MJ. Dutch digital breast cancer screening: implications for breast cancer care. Eur J Pub Health. 2012;22(6):925–9.CrossRef Timmers JM, den Heeten GJ, Adang EM, Otten JD, Verbeek AL, Broeders MJ. Dutch digital breast cancer screening: implications for breast cancer care. Eur J Pub Health. 2012;22(6):925–9.CrossRef
9.
go back to reference Domingo L, Romero A, Belvis F, Sanchez M, Ferrer J, Salas D, Ibanez J, Vega A, Ferrer F, Laso MS, et al. Differences in radiological patterns, tumour characteristics and diagnostic precision between digital mammography and screen-film mammography in four breast cancer screening programmes in Spain. Eur Radiol. 2011;21(9):2020–8.CrossRefPubMed Domingo L, Romero A, Belvis F, Sanchez M, Ferrer J, Salas D, Ibanez J, Vega A, Ferrer F, Laso MS, et al. Differences in radiological patterns, tumour characteristics and diagnostic precision between digital mammography and screen-film mammography in four breast cancer screening programmes in Spain. Eur Radiol. 2011;21(9):2020–8.CrossRefPubMed
10.
go back to reference Pisano ED, Hendrick RE, Yaffe MJ, Baum JK, Acharyya S, Cormack JB, Hanna LA, Conant EF, Fajardo LL, Bassett LW, et al. Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology. 2008;246(2):376–83.CrossRefPubMedPubMedCentral Pisano ED, Hendrick RE, Yaffe MJ, Baum JK, Acharyya S, Cormack JB, Hanna LA, Conant EF, Fajardo LL, Bassett LW, et al. Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology. 2008;246(2):376–83.CrossRefPubMedPubMedCentral
11.
go back to reference Skaane P, Skjennald A. Screen-film mammography versus full-field digital mammography with soft-copy reading: randomized trial in a population-based screening program--the Oslo II study. Radiology. 2004;232(1):197–204.CrossRefPubMed Skaane P, Skjennald A. Screen-film mammography versus full-field digital mammography with soft-copy reading: randomized trial in a population-based screening program--the Oslo II study. Radiology. 2004;232(1):197–204.CrossRefPubMed
12.
go back to reference Skaane P. Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review. Acta Radiol. 2009;50(1):3–14.CrossRefPubMed Skaane P. Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review. Acta Radiol. 2009;50(1):3–14.CrossRefPubMed
13.
go back to reference van Luijt PA, Fracheboud J, Heijnsdijk EA, den Heeten GJ, de Koning HJ. National Evaluation Team for breast cancer screening in Netherlands study G: nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens. Eur J Cancer. 2013;49(16):3517–25.CrossRefPubMed van Luijt PA, Fracheboud J, Heijnsdijk EA, den Heeten GJ, de Koning HJ. National Evaluation Team for breast cancer screening in Netherlands study G: nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens. Eur J Cancer. 2013;49(16):3517–25.CrossRefPubMed
14.
go back to reference Duffy SW, Dibden A, Michalopoulos D, Offman J, Parmar D, Jenkins J, Collins B, Robson T, Scorfield S, Green K, et al. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study. Lancet Oncol. 2016;17(1):109–14.CrossRefPubMedPubMedCentral Duffy SW, Dibden A, Michalopoulos D, Offman J, Parmar D, Jenkins J, Collins B, Robson T, Scorfield S, Green K, et al. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study. Lancet Oncol. 2016;17(1):109–14.CrossRefPubMedPubMedCentral
15.
go back to reference Bluekens AM, Karssemeijer N, Beijerinck D, Deurenberg JJ, van Engen RE, Broeders MJ, den Heeten GJ. Consequences of digital mammography in population-based breast cancer screening: initial changes and long-term impact on referral rates. Eur Radiol. 2010;20(9):2067–73.CrossRefPubMedPubMedCentral Bluekens AM, Karssemeijer N, Beijerinck D, Deurenberg JJ, van Engen RE, Broeders MJ, den Heeten GJ. Consequences of digital mammography in population-based breast cancer screening: initial changes and long-term impact on referral rates. Eur Radiol. 2010;20(9):2067–73.CrossRefPubMedPubMedCentral
16.
go back to reference de Munck L, de Bock GH, Otter R, Reiding D, Broeders MJ, Willemse PH, Siesling S. Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers. Br J Cancer. 2016;115(5):517–24.CrossRefPubMedPubMedCentral de Munck L, de Bock GH, Otter R, Reiding D, Broeders MJ, Willemse PH, Siesling S. Digital vs screen-film mammography in population-based breast cancer screening: performance indicators and tumour characteristics of screen-detected and interval cancers. Br J Cancer. 2016;115(5):517–24.CrossRefPubMedPubMedCentral
17.
go back to reference van Breest SV, Duijm LE, den Heeten GJ, Groenewoud JH, Jansen FH, Fracheboud J, Plaisier ML, van Doorne-Nagtegaal HJ, Broeders MJ. Two-view versus single-view mammography at subsequent screening in a region of the Dutch breast screening programme. Eur J Radiol. 2012;81(9):2189–94.CrossRef van Breest SV, Duijm LE, den Heeten GJ, Groenewoud JH, Jansen FH, Fracheboud J, Plaisier ML, van Doorne-Nagtegaal HJ, Broeders MJ. Two-view versus single-view mammography at subsequent screening in a region of the Dutch breast screening programme. Eur J Radiol. 2012;81(9):2189–94.CrossRef
18.
go back to reference National Evaluation Team for Breast cancer screening (NETB). National evaluation of breast cancer screening in the Netherlands 1990-2011/2012. In: Thirteenth evaluation report. Erasmus MC University Medical Center Rotterdam, Radboud University Nijmegen Medical Centre; 2014. National Evaluation Team for Breast cancer screening (NETB). National evaluation of breast cancer screening in the Netherlands 1990-2011/2012. In: Thirteenth evaluation report. Erasmus MC University Medical Center Rotterdam, Radboud University Nijmegen Medical Centre; 2014.
19.
go back to reference Bluekens AM, Holland R, Karssemeijer N, Broeders MJ, den Heeten GJ. Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study. Radiology. 2012;265(3):707–14.CrossRefPubMed Bluekens AM, Holland R, Karssemeijer N, Broeders MJ, den Heeten GJ. Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study. Radiology. 2012;265(3):707–14.CrossRefPubMed
20.
go back to reference Nederend J, Duijm LE, Louwman MW, Groenewoud JH, Donkers-van Rossum AB, Voogd AC. Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study. Ann Oncol. 2012;23(12):3098–103.CrossRefPubMed Nederend J, Duijm LE, Louwman MW, Groenewoud JH, Donkers-van Rossum AB, Voogd AC. Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study. Ann Oncol. 2012;23(12):3098–103.CrossRefPubMed
21.
go back to reference Nederend J, Duijm LE, Louwman MW, Coebergh JW, Roumen RM, Lohle PN, Roukema JA, Rutten MJ, van Steenbergen LN, Ernst MF, et al. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands. Eur J Cancer. 2014;50(1):31–9.CrossRefPubMed Nederend J, Duijm LE, Louwman MW, Coebergh JW, Roumen RM, Lohle PN, Roukema JA, Rutten MJ, van Steenbergen LN, Ernst MF, et al. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands. Eur J Cancer. 2014;50(1):31–9.CrossRefPubMed
22.
go back to reference Weber RJ, Nederend J, Voogd AC, Strobbe LJ, Duijm LE. Screening outcome and surgical treatment during and after the transition from screen-film to digital screening mammography in the south of The Netherlands. Int J Cancer. 2015;137(1):135–43.CrossRefPubMed Weber RJ, Nederend J, Voogd AC, Strobbe LJ, Duijm LE. Screening outcome and surgical treatment during and after the transition from screen-film to digital screening mammography in the south of The Netherlands. Int J Cancer. 2015;137(1):135–43.CrossRefPubMed
23.
go back to reference Karssemeijer N, Bluekens AM, Beijerinck D, Deurenberg JJ, Beekman M, Visser R, van Engen R, Bartels-Kortland A, Broeders MJ. Breast cancer screening results 5 years after introduction of digital mammography in a population-based screening program. Radiology. 2009;253(2):353–8.CrossRefPubMed Karssemeijer N, Bluekens AM, Beijerinck D, Deurenberg JJ, Beekman M, Visser R, van Engen R, Bartels-Kortland A, Broeders MJ. Breast cancer screening results 5 years after introduction of digital mammography in a population-based screening program. Radiology. 2009;253(2):353–8.CrossRefPubMed
24.
go back to reference Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med. 2014;174(3):448–54.CrossRefPubMed Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med. 2014;174(3):448–54.CrossRefPubMed
25.
go back to reference Louwman WJ, Voogd AC, van Dijck JA, Nieuwenhuijzen GA, Ribot J, Pruijt JF, Coebergh JW. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control. 2008;19(1):97–106.CrossRefPubMed Louwman WJ, Voogd AC, van Dijck JA, Nieuwenhuijzen GA, Ribot J, Pruijt JF, Coebergh JW. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control. 2008;19(1):97–106.CrossRefPubMed
26.
go back to reference Harmer C, Staples M, Kavanagh AM. Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening? Cancer Causes Control. 1999;10(5):333–7.CrossRefPubMed Harmer C, Staples M, Kavanagh AM. Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening? Cancer Causes Control. 1999;10(5):333–7.CrossRefPubMed
27.
go back to reference Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer. 2003;39(12):1718–29.CrossRefPubMed Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer. 2003;39(12):1718–29.CrossRefPubMed
29.
go back to reference Collaborative Group on Hormonal Factors in Breast C. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360(9328):187–95.CrossRef Collaborative Group on Hormonal Factors in Breast C. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360(9328):187–95.CrossRef
30.
go back to reference Helewa M, Levesque P, Provencher D, Lea RH, Rosolowich V, Shapiro HM, Breast Disease C, Executive C. Council SoO, Gynaecologists of C: breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can. 2002;24(2):164–80. quiz 181-164CrossRefPubMed Helewa M, Levesque P, Provencher D, Lea RH, Rosolowich V, Shapiro HM, Breast Disease C, Executive C. Council SoO, Gynaecologists of C: breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can. 2002;24(2):164–80. quiz 181-164CrossRefPubMed
32.
go back to reference Wald NJ, Murphy P, Major P, Parkes C, Townsend J, Frost C. UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. BMJ. 1995;311(7014):1189–93.CrossRefPubMedPubMedCentral Wald NJ, Murphy P, Major P, Parkes C, Townsend J, Frost C. UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. BMJ. 1995;311(7014):1189–93.CrossRefPubMedPubMedCentral
33.
go back to reference Hackshaw AK, Wald NJ, Michell MJ, Field S, Wilson AR. An investigation into why two-view mammography is better than one-view in breast cancer screening. Clin Radiol. 2000;55(6):454–8.CrossRefPubMed Hackshaw AK, Wald NJ, Michell MJ, Field S, Wilson AR. An investigation into why two-view mammography is better than one-view in breast cancer screening. Clin Radiol. 2000;55(6):454–8.CrossRefPubMed
34.
go back to reference Otten JD, Karssemeijer N, Hendriks JH, Groenewoud JH, Fracheboud J, Verbeek AL, de Koning HJ, Holland R. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst. 2005;97(10):748–54.CrossRefPubMed Otten JD, Karssemeijer N, Hendriks JH, Groenewoud JH, Fracheboud J, Verbeek AL, de Koning HJ, Holland R. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst. 2005;97(10):748–54.CrossRefPubMed
35.
go back to reference Heidinger O, Batzler WU, Krieg V, Weigel S, Biesheuvel C, Heindel W, Hense HW. The incidence of interval cancers in the German mammography screening program: results from the population-based cancer registry in North Rhine-Westphalia. Dtsch Arztebl Int. 2012;109(46):781–7.PubMedPubMedCentral Heidinger O, Batzler WU, Krieg V, Weigel S, Biesheuvel C, Heindel W, Hense HW. The incidence of interval cancers in the German mammography screening program: results from the population-based cancer registry in North Rhine-Westphalia. Dtsch Arztebl Int. 2012;109(46):781–7.PubMedPubMedCentral
36.
go back to reference Sala M, Comas M, Macia F, Martinez J, Casamitjana M, Castells X. Implementation of digital mammography in a population-based breast cancer screening program: effect of screening round on recall rate and cancer detection. Radiology. 2009;252(1):31–9.CrossRefPubMed Sala M, Comas M, Macia F, Martinez J, Casamitjana M, Castells X. Implementation of digital mammography in a population-based breast cancer screening program: effect of screening round on recall rate and cancer detection. Radiology. 2009;252(1):31–9.CrossRefPubMed
37.
go back to reference Hofvind S, Skaane P, Elmore JG, Sebuodegard S, Hoff SR, Lee CI. Mammographic performance in a population-based screening program: before, during, and after the transition from screen-film to full-field digital mammography. Radiology. 2014;272(1):52–62.CrossRefPubMedPubMedCentral Hofvind S, Skaane P, Elmore JG, Sebuodegard S, Hoff SR, Lee CI. Mammographic performance in a population-based screening program: before, during, and after the transition from screen-film to full-field digital mammography. Radiology. 2014;272(1):52–62.CrossRefPubMedPubMedCentral
38.
go back to reference Yankaskas BC, Klabunde CN, Ancelle-Park R, Renner G, Wang H, Fracheboud J, Pou G, Bulliard JL. International breast cancer screening N: international comparison of performance measures for screening mammography: can it be done? J Med Screen. 2004;11(4):187–93.CrossRefPubMed Yankaskas BC, Klabunde CN, Ancelle-Park R, Renner G, Wang H, Fracheboud J, Pou G, Bulliard JL. International breast cancer screening N: international comparison of performance measures for screening mammography: can it be done? J Med Screen. 2004;11(4):187–93.CrossRefPubMed
39.
go back to reference Hoff SR, Abrahamsen AL, Samset JH, Vigeland E, Klepp O, Hofvind S. Breast cancer: missed interval and screening-detected cancer at full-field digital mammography and screen-film mammography-- results from a retrospective review. Radiology. 2012;264(2):378–86.CrossRefPubMed Hoff SR, Abrahamsen AL, Samset JH, Vigeland E, Klepp O, Hofvind S. Breast cancer: missed interval and screening-detected cancer at full-field digital mammography and screen-film mammography-- results from a retrospective review. Radiology. 2012;264(2):378–86.CrossRefPubMed
Metadata
Title
Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening
Authors
Valérie D. V. Sankatsing
Jacques Fracheboud
Linda de Munck
Mireille J. M. Broeders
Nicolien T. van Ravesteyn
Eveline A. M. Heijnsdijk
André L. M. Verbeek
Johannes D. M. Otten
Ruud M. Pijnappel
Sabine Siesling
Harry J. de Koning
National Evaluation Team for Breast cancer screening, NETB
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4122-2

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine